Q — Qnity Electronics, Inc.

The sell side is one-sidedly bullish and the tape is not. As of 2026-09-13, FMP shows 4 buy ratings, 0 holds and 0 sells with a $179.80 consensus price target from 3 analysts (low $165, high $189), while the live research brief claims 9 analysts at ~1.1 average recommendation and targets up to $198.45 — a real discrepancy between the two sources worth flagging rather than smoothing over. Insider behavior supports the bulls: Director Bondt De bought 1,000 shares at $138.14 on 2026-08-11, roughly 9% above the current price. But the market's own vote has been negative: -16.1% over three months and -11.0% over one month into 2026-09-13, price still below its 50-day SMA, and RSI at a neutral 48.4 with no oversold washout. The net is a divided tape — bullish consensus estimates versus a stock that has been de-rating for a quarter — which is Neutral sentiment, not Bullish.

Revenue is inflecting UP, not decelerating: $1,118M (Q1'25) → $1,170M (Q2'25) → $1,276M (Q3'25) → $1,190M (Q4'25) → $1,315M (Q1'26) → $1,429M (Q2'26). YoY growth went from +6.1% in Q2'25 to +17.6% in Q1'26 and +22.1% in Q2'26, with sequential gains of +10.5% then +8.7%. Gross margin is the standout and looks structural: 41.9% (Q2'25), 41.1% (Q3'25, the low), 41.8% (Q4'25), 43.0% (Q1'26), 46.6% (Q2'26) — a 470bp YoY expansion and 550bp off the trough. None of that is reaching the bottom line yet. Operating margin in Q2'26 was 19.3% versus 21.2% a year earlier despite gross profit rising $176M YoY, which means roughly $138M of incremental opex (R&D was only +$10M) absorbed the entire gross-profit gain — the classic signature of a newly standalone company carrying separation and public-company costs that did not exist in the carve-out. Net income fell to $124M from $188M and diluted EPS to $0.59 from $0.90; Q4'25 was the reported trough at $100M/$0.48, the quarter in which long-term debt jumped from $1.72B (2025-09-30) to $4.46B and stockholders' equity fell ~$3.8B (from $10.93B at 2025-06-30 to $7.10B at 2025-12-31). Cash is positive but softening: Q2'26 operating cash flow of $241M was -11.7% YoY and Q1'26's $135M was -34.8%, with capex nearly doubling YoY ($90M vs $49M) leaving FCF of $13M and $151M vs $103M and $224M a year earlier. Bottom line: a genuine demand and gross-margin upturn colliding with a one-time-heavy cost and capital-structure reset. The revenue and gross-margin lines look structural; the EPS and FCF declines look transitional — but that is precisely what has not yet been proven in reported numbers.

As of 2026-09-13 at $126.40, Qnity trades at 45.1x TTM GAAP EPS of $2.796, 5.08x TTM sales ($5.21B), 3.65x book and ~20.4x TTM EV/EBITDA. Against its own 5-year averages of 29.67x P/E and 4.34x P/S — averages built on only 4 data years for a company with ~10 months of independent trading history, so treat them as a rough reference, not gospel — the stock is rich, and the deterministic model's valuation overlay agrees, scoring 14.4/100 and labeling it 'Rich vs. its own history.' The counterargument is forward earnings: on next-FY consensus EPS of $4.553 the multiple compresses to 27.8x, and the $5.61B revenue estimate implies roughly 16-17x forward EV/EBITDA — inside the 13-18x band where semis-materials peers like Entegris and MKS typically trade. The PEG of 0.838 is flattered by a depressed TTM base and should not be taken at face value. Verdict: expensive on reported numbers, roughly fair-to-slightly-rich on consensus adjusted numbers, with the entire valuation case resting on the GAAP-to-adjusted bridge actually closing.

This is an 'estimates must be validated' setup, not a buy-the-trough setup. The gap is stark: TTM GAAP EPS is $2.796 and next-FY consensus is $4.553, a 63% step-up, while the most recent quarter printed $0.59 of GAAP EPS, down 34% YoY. At $126.40 the market is paying 27.8x earnings that have not yet appeared in any filing — so the stock is priced for the spinoff cost base and interest drag to roll off, not for current profitability. If GAAP EPS keeps running near $0.60-0.72 a quarter (~$2.5-2.9 annualized), the real multiple is 44-50x and there is no cushion. If the $4.55 is real, 27.8x forward for a business growing revenue 22% with 46.6% gross margins is defensible. Practical playbook: watch the non-GAAP-to-GAAP bridge each quarter — specifically the standalone SG&A run-rate, interest expense on the ~$4.0B of long-term debt, and whether gross-margin expansion keeps passing through to operating income. The stock re-rates when operating margin follows gross margin; it de-rates hard if it doesn't.

As of 2026-09-13, RSI(14) stood at 48.37 — dead neutral, neither overbought nor oversold. Price was +0.29% versus the 20-day SMA (essentially flat), -4.89% versus the 50-day SMA (roughly $132.9, now resistance) and +3.13% versus the 200-day SMA (roughly $122.6, now support). The stock sits almost exactly mid-range — 52.3% of the way from the $70.50 low to the $177.28 high — having bounced +4.92% on the week while still down 11.04% on the month and 16.10% on the quarter. Read it as a three-month downtrend that is attempting to base above its 200-day, with the 50-day capping every rally since June. Entry-timing implication: there is no oversold washout to buy here; the higher-probability entries are either a decisive reclaim of ~$133 on volume (trend confirmation) or a retest of ~$122 with RSI back under 35 (valuation plus sentiment reset).

• AI/HPC and advanced-packaging capex: Qnity's advanced packaging materials, interconnect and high-end PCB products sit directly in the chiplet / 2.5D-3D and data-center buildout — the single largest demand swing factor, and the reason Q2 2026 revenue grew 22.1% YoY.
• Semiconductor cycle and inventory correction: as a tier-1 materials supplier, volumes lag foundry and OSAT utilization; a memory or logic digestion phase would hit revenue and the 45x trailing multiple at the same time.
• Interest rates and duration risk: a 45.1x trailing P/E on 5.08x sales makes the multiple highly rate-sensitive, and the ~$4.0B of long-term debt pushed on at separation (D/E 0.554) is a genuine refinancing-rate exposure as well as an earnings drag.
• US-China export controls, tariffs and regional fab incentives (CHIPS-style subsidies) reshape where Qnity's customers build capacity, adding both compliance cost and demand volatility by geography.
• Post-spinoff index and ownership dynamics: S&P 500 inclusion plus mandate-driven selling/buying around the DuPont separation distort near-term supply/demand independently of fundamentals.

• Q3 2026 earnings (likely early-to-mid November 2026, based on the 2025-11-18 filing for Q3 2025) — the single most important datapoint: does the 46.6% gross margin convert into operating-margin expansion above Q2 2026's 19.3%?
• First full standalone-year guidance and any disclosure of the run-rate standalone SG&A / separation cost base, plus order-visibility commentary on advanced packaging lines.
• Capital allocation against the debt: with $961M cash versus ~$4.0B long-term debt and Q2 2026 FCF of $151M, any deleveraging, buyback initiation or dividend step-up would be a re-rating signal.
• Analyst coverage expansion (only 3 price targets appear in the FMP set versus the brief's claimed 9 raters) and whether the $165-189 target cluster holds if GAAP EPS does not recover.
• Follow-through on insider/institutional accumulation — Director Bondt De's 1,000-share purchase at $138.14 on 2026-08-11 sits above the 2026-09-13 price of $126.40 and is worth tracking.

• The GAAP-to-adjusted earnings gap: TTM GAAP diluted EPS of $2.796 versus a $4.553 next-FY consensus (a 63% step-up) while Q2 2026 GAAP EPS of $0.59 fell 34% YoY. If separation and standalone costs are structural rather than one-time, forward estimates get cut and the 45x trailing multiple has nothing underneath it.
• Leverage and weak returns: ~$4.0B long-term debt against $961M cash, TTM ROIC of just 6%, ROE 9.8% and net margin 11.2% — debt service consumes a large share of operating income, and the ~$3.8B equity reduction between 2025-06-30 and 2025-12-31 shows how much the capital structure changed at separation.
• Cyclical demand risk: Qnity sells into foundry and OSAT production, so a semiconductor digestion phase would cut materials volumes at the same time as compressing a rich multiple.
• Valuation/mean reversion: 45.1x trailing P/E and 5.08x sales versus a 4.34x 5-year average P/S, with the deterministic model explicitly labeling it 'Rich vs. its own history' (valuation overlay 14.4/100). Beta of 1.631 amplifies drawdowns.
• Post-spinoff execution and disclosure risk: only about four quarters of standalone financials exist, and pre-separation carve-out comparatives overstated equity while understating standalone costs.
• Technical downtrend: down 16.1% over three months and trading below its 50-day SMA as of 2026-09-13, with the 52-week high 29% above the current price.

Honest read: a good-but-not-elite business at a full price, with the bull case not yet proven. Revenue is genuinely re-accelerating (+22.1% YoY in Q2 2026) and gross margin has expanded 550bp off the Q3 2025 bottom, but GAAP EPS fell to $0.59 from $0.90, FCF fell to $151M from $224M, and TTM ROIC is only 6% against ~$4.0B of separation-date debt — so the 27.8x forward multiple and the street's $165-189 targets require the cost and interest drag to roll off, which has not happened yet in any filing. At $126.40 on 2026-09-13, with RSI at 48.4 and price still under its 50-day SMA, I would rather wait for the Q3 2026 print to show gross-margin gains reaching operating income than pay up 11% off the recent low for a thesis the reported numbers do not yet support.

Blended two forward-looking methods as of 2026-09-13: (1) 27x next-FY consensus adjusted EPS of $4.553 = $123/share, a mid-range semis-materials multiple sitting between the stock's current 27.8x forward and ~29.7x 5-year average P/E, discounted for 6% ROIC and new leverage; (2) 17x forward EBITDA of ~$1.80B (derived from $4.553 EPS on 209.3M shares, grossed up for ~23% tax and ~$180M interest, plus ~$380M D&A), less $3.04B net debt on 209.3M shares = ~$132/share, at the top of the 13-18x peer EV/EBITDA range. Averaging the two outputs ($122.93 and $131.67) yields $127.30 — essentially the current price, which is why I read Qnity as fairly valued rather than the bargain the $165-189 street target cluster implies.